David M. Kendall
Chief Tech/Sci/R&D Officer chez ZEALAND PHARMA A/S
Profil
David M.
Kendall is currently the Chief Medical Officer at Zealand Pharma A.
Prior to this, he worked as the Chief Medical Officer at MannKind Corp.
from 2018 to 2020, and as the Vice President-Global Medical Affairs at Eli Lilly & Co. from 2011 to 2018.
He also served as the Medical Director at Amylin Pharmaceuticals, Inc. from 2005 to 2008, and as the Medical Director at the International Diabetes Center from 1997 to 2009.
Additionally, he was the Chief Scientific & Medical Affairs Officer at the American Diabetes Association from 2009 to 2011.
Kendall's education includes an undergraduate degree from St. Olaf College in 1983 and a doctorate from the University of Minnesota in 1988.
Postes actifs de David M. Kendall
| Sociétés | Poste | Début |
|---|---|---|
| ZEALAND PHARMA A/S | Chief Tech/Sci/R&D Officer | 02/06/2022 |
Anciens postes connus de David M. Kendall
| Sociétés | Poste | Fin |
|---|---|---|
| MANNKIND CORPORATION | Chief Tech/Sci/R&D Officer | 28/08/2020 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01/02/2018 |
| Lilly Diabetes | Corporate Officer/Principal | 01/01/2018 |
American Diabetes Association
 American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Chief Tech/Sci/R&D Officer | 01/07/2011 |
International Diabetes Center
 International Diabetes Center Miscellaneous Commercial ServicesCommercial Services International Diabetes Center is a non-profit healthcare organization that provides diabetic treatment and research services. The private company is based in St. Louis Park. | Chief Tech/Sci/R&D Officer | 01/09/2009 |
Formation de David M. Kendall
| St. Olaf College | Undergraduate Degree |
| University of Minnesota | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| MANNKIND CORPORATION | Health Technology |
| ZEALAND PHARMA A/S | Health Technology |
| Entreprise privées | 5 |
|---|---|
Amylin Pharmaceuticals, Inc.
 Amylin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Amylin Pharmaceuticals, Inc. develops and commercializes medicines for diabetes, obesity, and cardiovascular diseases. The company was founded on September 29, 1987 by Howard E. Greene, Jr. and is headquartered in San Diego, CA. | Health Technology |
American Diabetes Association
American Diabetes Association Miscellaneous Commercial ServicesCommercial Services American Diabetes Association provides diabetes related medical services. It funds research, publishes scientific findings, provides information and other services to people with diabetes, their families, health professionals and the public. The company was founded in 1940 and is headquartered in Alexandria, VA. | Commercial Services |
Park Nicollet Health Services
 Park Nicollet Health Services Hospital/Nursing ManagementHealth Services Park Nicollet Health Services provides healthcare services. It operates Methodist Hospital, Park Nicollet Clinic, the Park Nicollet Foundation, and Park Nicollet Institute. It offers services such as vision correction, cancer treatment, rehabilitation, and plastic surgery. The company is headquartered in St. Louis Park, MN. | Health Services |
International Diabetes Center
International Diabetes Center Miscellaneous Commercial ServicesCommercial Services International Diabetes Center is a non-profit healthcare organization that provides diabetic treatment and research services. The private company is based in St. Louis Park. | Commercial Services |
| Lilly Diabetes |
